Drug Trial Radar · NCT05468554
Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer
Last checked: Nov 20, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Nov 1, 2022
Primary completion
Jan 31, 2028
Study completion Apr 30, 2028
Sponsor
- Lead sponsor
- Medical University of BialystokAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medical Research Agency, Poland; Holy Cross Cancer Center in Kielce; University Clinical Hospital in Poznań; Maria Skłodowska-Curie National Research Institute of Oncology; University Clinical Hospital in Białystok
- First posted
- Jul 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is aimed to investigate the metformin effect on the fertility of women treated with 131 I for thyroid cancer
Conditions
- Thyroid Cancer
Interventions
metforminDrug
Metformin will be used 3 times a day (3x500mg), starting in the first week with 1x1 tablet (1x500 mg for breakfast), in the second week, 2x1 tablet (500 mg for breakfast and 500 mg for dinner), from the 3rd week 3x1 tablet. (3x500mg with main meals). A gradual escalation of the dose is planned to the point of developing drug intolerance or toxicity that is unacceptable to the patient.
Radioactive iodine (I-131)Radiation
Patients qualified to receive 131I treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in AMH, Inhibin B and FSH levels due to the action of metforminTime frame: 4 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Department of Endocrinology, Diabetology and Internal Medicine, Medical Univeristy of Bialystok
Bialystok, Poland · Recruiting
Holy Cross Cancer Center
Kielce, Świetokrzystie, Poland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.